|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 12830484.7 (espacenet) (Federated) (European Patent Register), 20120905 | | Patent/reg. no. and date | DK/EP 2754440, 20190403 | | Publication date | 20140716 | | Priority no. and date | JP 2011192288, 20110905 | | EP pub. no. and date |
EP 2754440 20140716 | | Effective date | | | Applicant/owner | Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku
Osaka-shi
Osaka 541-8505, JP | | Applicant ref. no. | V1057DKEP | | Inventor | YONEOKA, Takatomo, c/o MITSUBISHI TANABE PHARMA CORPORATION
6-18 Kitahama 2-chome
Chuo-ku
Osaka-shi
Osaka 541-8505, JP | | Representative | COPA COPENHAGEN PATENTS K/S, Rosenvængets Allé 25, 2100 København Ø | | Opponent | | | IPC Class | A61K 31/4152 (2006.01) , A61P 25/28 (2006.01) , C07D 231/26 (2006.01) | | Title | Lægemiddel til behandling af amyotrofisk lateral sklerose eller forebyggelse af progression af fase af amyotrofisk lateral sklerose | | Int. application no. | JP2012072544 | | Int. publication no. | WO2013035712 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
